Stockreport

Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024 [Yahoo! Finance]

Opthea Limited - American Depositary Shares  (OPT) 
PDF biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced it will host a virtual key opinion leade [Read more]